FDA issued a new final guidance for industry on the action levels for lead in processed food intended for babies and young children. Action levels are levels of a contaminant at which the agency may consider a food to be adulterated.
The European Food Safety Authority’s (EFSA’s) most recent report on emerging risk activities identifies food safety issues on the horizon posed by chemical and biological hazards, and new processes and technologies.
The U.S. Food and Drug Administration (FDA) has announced that January 1, 2028 will be the uniform compliance date for all final food labeling regulations published between January 1, 2025 and December 31, 2026.
The U.S. Food and Drug Administration (FDA) has announced that the food contact notifications for 35 per- and polyfluoroalkyl substances (PFAS) are no longer effective, due to the abandonment of their uses by industry.
The U.S. Food and Drug Administration (FDA) recently began a national sampling and testing assignment for Highly Pathogenic Avian Influenza H5N1 (HPAI H5N1) in raw cow’s milk cheese.
In this episode of Food Safety Matters, we discuss the top food safety stories of 2024 and their implications, including high-profile foodborne illness outbreaks, the ongoing avian flu outbreak in poultry and dairy cattle, FDA’s Human Foods Program restructuring, rising concerns and evolving legislation around food additives and chemical contaminants, and other topics.
In light of the global Highly Pathogenic Avian Influenza H5N1 (HPAI H5N1) outbreak, and considering the virus’ spread from poultry to dairy cows in North America, FAO has published recommendations for monitoring for HPAI H5N1 in cattle.
After a poisoning outbreak linked to “legal” mushroom-based edibles sold across the country, the U.S. Food and Drug Administration (FDA) has informed industry that the mushroom Amanita muscaria is not authorized for use as an ingredient in food.
Earthjustice sued FDA on behalf of consumer advocates that previously petitioned FDA to revoke food contact authorizations for 28 phthalates, and were denied. Although FDA since revoked authorizations for many of those phthalates and says the rest are under review, the plaintiffs hope their lawsuit will force a long-overdue safety reassessment.
RSS
